Allogeneic stem cell transplantation for chronic myeloid leukemia

被引:41
作者
Barrett, J [1 ]
机构
[1] NHLBI, Stem Cell Allotransplantat Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1053/shem.2003.50003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:59 / 71
页数:13
相关论文
共 98 条
[1]   Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant [J].
Alyea, EP ;
Soiffer, RJ ;
Canning, C ;
Neuberg, D ;
Schlossman, R ;
Pickett, C ;
Collins, H ;
Wang, YL ;
Anderson, KC ;
Ritz, J .
BLOOD, 1998, 91 (10) :3671-3680
[2]   Graft-versus-leukaemia [J].
Barrett, AJ ;
vanRhee, F .
BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02) :337-355
[3]   Mechanisms of the graft-versus-leukemia reaction [J].
Barrett, AJ .
STEM CELLS, 1997, 15 (04) :248-258
[4]   T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect [J].
Barrett, AJ ;
Mavroudis, D ;
Tisdale, J ;
Molldrem, J ;
Clave, E ;
Dunbar, C ;
Cottler-Fox, M ;
Phang, S ;
Carter, C ;
Okunnieff, P ;
Young, NS ;
Read, EJ .
BONE MARROW TRANSPLANTATION, 1998, 21 (06) :543-551
[5]  
Barrett AJ, 2000, BLOOD, V95, P3323
[6]   Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia [J].
Barta, A ;
Dénes, R ;
Masszi, T ;
Reményi, P ;
Bátai, A ;
Torbágyi, É ;
Sipos, A ;
Lengyel, L ;
Jakab, K ;
Gyódi, É ;
Réti, M ;
Földi, J ;
Páldi-Haris, P ;
Avalos, M ;
Pálóczi, K ;
Fekete, S ;
Török, J ;
Hoffer, I ;
Jakab, J ;
Váradi, G ;
Kelemen, E ;
Petrányi, G .
ACTA HAEMATOLOGICA, 2001, 105 (02) :64-70
[7]   The adverse influence of pretransplant interferon-α (IFN-α) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-α exposure [J].
Beelen, DW ;
Elmaagacli, AH ;
Schaefer, UW .
BLOOD, 1999, 93 (05) :1779-1780
[8]   Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation [J].
Brandenburg, U ;
Gottlieb, D ;
Bradstock, K .
LEUKEMIA & LYMPHOMA, 1998, 31 (5-6) :545-550
[9]  
Carreras E, 2000, HAEMATOLOGICA, V85, P530
[10]   Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy [J].
Champlin, R ;
Khouri, I ;
Shimoni, A ;
Gajewski, J ;
Kornblau, S ;
Molldrem, J ;
Ueno, N ;
Giralt, S ;
Anderlini, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :18-29